Elutia (ELUT) to Release Earnings on Wednesday

Elutia (NASDAQ:ELUT) is scheduled to post its quarterly earnings results after the market closes on Wednesday, August 7th.

Elutia (NASDAQ:ELUT) last released its quarterly earnings results on Thursday, May 9th. The company reported ($0.75) earnings per share (EPS) for the quarter. The business had revenue of $6.69 million during the quarter.

Elutia Price Performance

Shares of ELUT traded up $0.16 during midday trading on Wednesday, hitting $3.79. The stock had a trading volume of 863 shares, compared to its average volume of 40,639. The company has a 50 day simple moving average of $3.84 and a two-hundred day simple moving average of $3.51. Elutia has a twelve month low of $1.10 and a twelve month high of $5.24. The firm has a market cap of $91.98 million, a price-to-earnings ratio of -1.53 and a beta of 0.72.

Analyst Ratings Changes

Several research firms have issued reports on ELUT. Lake Street Capital lifted their price target on Elutia from $5.00 to $10.00 and gave the company a “buy” rating in a research note on Friday, June 21st. Cantor Fitzgerald boosted their price target on Elutia from $5.00 to $11.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 18th.

About Elutia

Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.